Switch to:
More From Other Websites
GSK-Novartis deal wins US trade regulator approval Nov 27 2014
Regulatory update on transaction with Novartis Nov 27 2014
Regulatory update on transaction with Novartis Nov 26 2014
U.S. approves GSK's purchase of Novartis vaccine business-companies Nov 26 2014
Novartis selling nicotine patch to win U.S. nod for GlaxoSmithKline deal - FTC Nov 26 2014
Novartis to Divest Nicotine Patch Habitrol Nov 26 2014
Novartis selling nicotine patch to win U.S. nod for GlaxoSmithKline deal -FTC Nov 26 2014
Novartis selling nicotine patch to win U.S. nod for GlaxoSmithKline deal -FTC Nov 26 2014
Novartis selling nicotine patch to win U.S. nod for GlaxoSmithKline deal -FTC Nov 26 2014
Novartis' Multiple Myeloma Drug FDA Action Date Delayed Nov 26 2014
1:21 am Novartis announces extension to FDA review period for multiple myeloma investigational... Nov 25 2014
Novartis' Psoriasis Drug Cosentyx Backed for EU Approval Nov 24 2014
Can Partnering To Fight Hepatitis C Pay At Enanta? Nov 24 2014
Novartis Dismisses Employee who Fabricated Data in Research Papers Nov 24 2014
GSK shareholders to vote on Novartis deal on Dec. 18 Nov 24 2014
GSK shareholders to vote on Novartis deal on Dec. 18 Nov 24 2014
GSK shareholders to vote on Novartis deal on Dec. 18 Nov 24 2014
Novartis Wins European Backing for Psoriasis Drug Cosentyx Nov 21 2014
Novartis Foundation symposium showcases sustainable healthcare interventions » Nov 21 2014
Novartis Cosentyx(TM) receives positive CHMP opinion for first-line treatment of moderate-to-severe... Nov 21 2014
New 'Hutch' Director Aims To Push Toward Cancer Cures Based On The Immune System Nov 20 2014
Health Care dominates the Lg Cap All-Time Highs today... Nov 18 2014
Novartis Presents Data on Heart Failure Candidate LCZ696 Nov 18 2014
World's top drugmaker Novartis takes aim at tech Nov 18 2014
Actavis to buy Botox maker Allergan for $66B Nov 17 2014
Will IPOs WhiteWave, Enanta Surpass Buy Points? Nov 17 2014
Nine new analyses show Novartis' LCZ696 could change course of heart failure for patients[1],[2] » Nov 17 2014
Incyte Building Blockbuster Drug One Disease At A Time Nov 17 2014
World's top drugmaker Novartis takes aim at tech Nov 17 2014
World's top drugmaker Novartis takes aim at tech Nov 17 2014
[$$] Asia Corporate Watch Nov 16 2014
[$$] Novartis Drug Posts Positive Data Nov 15 2014
Novartis 'in the right place' with business: CEO Nov 12 2014
Novartis and Malaria No More help fulfill malaria treatment goal in Zambia by raising funds for... Nov 12 2014
Novartis to reveal landmark Phase III data for AIN457 (secukinumab) in psoriatic arthritis and... Nov 10 2014
Novartis' (NVS) LBH589 Gets Unfavorable FDA Panel Opinion Nov 07 2014
Novartis announces outcome of FDA advisory committee meeting for multiple myeloma investigational... Nov 06 2014
The Oracle of Tampa's top picks Nov 03 2014
Swiss drug maker Novartis posts strong profit Oct 28 2014
Swiss drug maker Novartis posts 3Q profit Oct 28 2014
Novartis results top forecasts as new products gain momentum Oct 28 2014
Novartis sees new heart failure drug as 'multi-blockbuster' Oct 28 2014
Novartis delivered solid sales growth with strong margin expansion and major innovation in the third... Oct 28 2014
Novartis selling flu vaccine unit to CSL for $275M Oct 27 2014
Australia's CSL buys Novartis flu vaccine unit for $275 mln Oct 27 2014
Novartis reports positive results in spinal inflammation condition Oct 23 2014
Novartis AIN457 (secukinumab) meets primary endpoint in two Phase III studies in ankylosing... Oct 23 2014
Novartis announces FDA Advisory Committee unanimously recommends approval of AIN457 (secukinumab)... Oct 20 2014
Novartis announces CTL019 data published in NEJM demonstrating efficacy in certain patients with... Oct 15 2014
Novartis aims for a bigger share of the global anti-cancer drugs market with a stake in Oxford... Oct 12 2014
BUZZ-Oxford Biomedica: Signs 3-year deal with Novartis Oct 10 2014
Oxford Biomedica strikes 'transformational' $90m deal with Novartis Oct 09 2014
Shareholder group critical as Roche and Novartis chiefs top Swiss pay table Oct 08 2014
Novartis says three executives to leave after GSK, Lilly deals Oct 08 2014
Novartis says 3 executives to leave after GSK, Lilly deals Oct 08 2014
EU OKs Eli Lilly's $5.4B bid for Novartis division Oct 03 2014
Novartis Japan admits concealing drug side effects Sep 01 2014
Novartis Japan admits concealing drug side effects Sep 01 2014
Tests promise 'blockbuster' new heart failure drug Aug 31 2014
Tests promise 'blockbuster' new heart failure drug Aug 30 2014
Novartis loses new bid to dismiss U.S. lawsuit over kickbacks Aug 07 2014
Novartis cites momentum in 3 percent profit rise Jul 17 2014
Drugmaker Novartis to eke out more cost savings to lift margins Jul 17 2014
Novartis and Google to develop 'smart' contact lens Jul 15 2014
Novartis and Google to develop 'smart' contact lens Jul 15 2014
Novartis hopes to commercialise "smart lens" within 5 years Jul 15 2014
Novartis faces criminal charge in Japan Jul 01 2014
Novartis: drug costs can come down with fewer 'fails' Jun 28 2014
Novartis, Pfizer seek U.S. approval of meningitis vaccines Jun 17 2014
Novartis submits application to the FDA for meningitis B vaccine candidate Bexsero® to help protect... Jun 17 2014
Tokyo prosecutors raid Novartis Japan unit over clinical data probe Jun 11 2014
Novartis appoints Merck executive as oncology chief Jun 01 2014
Italy seeks 1.2 bn euros in damages from Roche, Novartis May 28 2014
Italy seeks 1.2 bn euros in damages from Roche, Novartis May 28 2014
Novartis, Sun Pharma settle dispute over generic Gleevec May 15 2014
First Myelofibrosis Medication for Life-threatening Blood Cancer Approved in Singapore May 14 2014
Novartis lung drug not inferior to GSK's Seretide, study shows Apr 25 2014
Pharma giant Novartis sees net profit jump 24% Apr 24 2014
Pharma giant Novartis sees net profit jump 24% Apr 23 2014
Novartis, Valeant bids herald new deal-making era for pharma Apr 22 2014
Novartis and GSK trade assets as pharma industry reshapes Apr 22 2014
Novartis reshapes business via deals with GSK and Lilly Apr 22 2014
Shake-up in pharma world as Novartis, GSK announce mega-deals Apr 22 2014
Drugmaker Novartis files patent suit against Biocon over Galvus Apr 03 2014
Novartis to cut or transfer up to 4,000 pharma jobs - paper Feb 02 2014


Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

No comment yet


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK